Clinical Trials · NCT00765882

Phase III, Randomized, Double-Blind, Placebo-Controlled, Trial of Linaclotide Administered to Patients With Chronic Constipation

Name: Phase III, Randomized, Double-Blind, Placebo-Controlled, Trial of Linaclotide Administered to Patients With Chronic Constipation
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 3Linaclotide

Phase: Phase 3
Recruitment status: Completed
Sponsor: Forest Laboratories
Enrollment: 633
Start date: Sep 2008
Locations: 108 sites, United States, Canada
Primary endpoint: Complete Spontaneous Bowel Movement (CSBM) Overall Responder

View Linaclotide compound reference